Baxter Healthcare product recalled over manufacturing violations
- Recall date
- September 6, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Baxter Healthcare Corporation recalls 0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 033…
- Recall number
- D-1190-2018
- FDA classification
- Class II
- Brand / firm
- Baxter Healthcare Corporation
- Sold / distributed
- Nationwide.
Why it was recalled
cGMP Deviation
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31
Get recall alerts
Free email alert whenever Baxter Healthcare Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Baxter Healthcare Corporation